Skip to content

Anxiety: all studies

Page 213 of 772: studies 2,121 to 2,130 of 7,715, newest first. Back to the anxiety overview

Research

Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users

July 28, 2024 Jonathan David, Aviva Berkovich-Ohana, Yair Dor-Ziderman 2 citations preprint

Background: How the human psyche interacts with the theme of death is fundamental to individual and societal life, profoundly influencing cognition, affect, and behavior. Death-related psychological phenomena, such as death anxiety and acceptance, have been shown in clinical studies to be influenced by psychedelic (LSD and psilocybin) interventions. However, the literature lacks a comprehensive...

Assessing the Impact of the Mindfulness-Based Body Scan Technique on Sleep Quality in Multiple Sclerosis Using Objective and Subjective Assessment Tools: Single-Case Study.

JMIR Formative Research July 25, 2024 Ioannis Iliakis, Maria Anagnostouli, George P Chrousos 1 citation

Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system, often leading to poor sleep quality and diminished quality of life (QoL) for affected patients. Sleep disturbances in MS do not always correlate linearly with other symptoms such as anxiety, depression, fatigue, or pain. Various approaches, including stress reduction techniques such as...

PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin

Journal of Advances in Medicine and Medical Research July 24, 2024 Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa et al.

Post-Traumatic Stress Disorder (PTSD) is a debilitating mental health condition that can occur after experiencing or witnessing a traumatic event. The impact of PTSD extends beyond the individual, affecting families, communities, and society as a whole. This study aims to investigate the potential of psilocybin as a treatment for PTSD. Psilocybin, after being metabolized to psilocin, binds to...

Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report

Frontiers in Psychiatry July 16, 2024 André Do, Vanessa Michaud, Jean-François Stephan et al. 3 citations

Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case...

Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions

Journal of Anesthesia and Translational Medicine July 11, 2024 Kenji Hashimoto, Mingming Zhao, Tingting Zhu et al. 32 citations

Ketamine, a dissociative anesthetic, is widely utilized in both human and veterinary anesthesia. Its (S)-enantiomer, esketamine, is similarly employed for anesthesia and analgesia. The anesthetic effects of both ketamine and esketamine arise from their antagonism of the N-methyl-D-aspartate receptor (NMDAR). In field of psychiatry, the rapid-acting antidepressant properties of ketamine for...

Yoga as a Contemplative Practice and Its Contribution to Participatory Self-Knowledge and Student Retention: A Scoping Review of the First-Year Undergraduate Student Transition.

International Journal of Environmental Research and Public Health July 7, 2024 Beverley Martin, Blake Peck, Daniel Terry 5 citations

Contemplative pedagogy, specifically yoga, introduced into the higher education curriculum has the potential to develop and entrain intellectual, emotional, and social development in relation to mental health among university students studying for medical and nursing degrees. The objective of the study is to determine the extent of the current literature on the prevalence of yoga as a...

Prevalence and 20-year trends in meditation, yoga, guided imagery and progressive relaxation use among US adults from 2002 to 2022

Scientific Reports July 1, 2024 Jonathan N. Davies, Anna Faschinger, Julieta Galante et al. 45 citations

Meditation, yoga, guided imagery, and progressive relaxation are promoted as complementary approaches for health and wellbeing in the United States, but their uptake by different sociodemographic groups is unclear. This study assessed the prevalence and 20 year trends in the use of these practices in US adults between 2002-2022. We examined practice use and associations with sociodemographic...

Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress.

Neuropharmacology July 1, 2024 Kevin T Krupp, Jazmine D W Yaeger, Leighton J Ledesma et al. 11 citations

Psychedelic compounds have potentially rapid, long-lasting anxiolytic, antidepressive and anti-inflammatory effects. We investigated whether the psychedelic compound (R)-2,5-dimethoxy-4-iodoamphetamine [(R)-DOI], a selective 5-HT2A receptor partial agonist, decreases stress-related behavior in male mice exposed to repeated social aggression. Additionally, we explored the likelihood that these...

Impact of Mind-Body Interventions on Psychosocial and Bio Physiological Markers among Elderly.

Journal of pharmacy & bioallied sciences July 1, 2024 Jayalakshmi Lakshmanan, Bhuvaneswari Gopalakrishnan, Shankar Shanmugam Rajendran 1 citation

The global demographic shift toward an older population is witnessing an increase in age-related psychological disorders and chronic illnesses, particularly among those residing in old age homes. Mind-body interventions (MBIs) have shown promise in enhancing mental and physical health without the adverse effects associated with pharmaceuticals. This quasi-experimental study involved 42 elderly...

The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats.

Psychopharmacology July 1, 2024 Dilan Gokalp, Gunes Unal

Ketamine produces dissociative, psychomimetic, anxiolytic, antidepressant, and anesthetic effects in a dose dependent manner. It has a complex mechanism of action that involve alterations in other glutamate receptors. The metabotropic glutamate receptor 5 (mGluR5) has been investigated in relation to the psychotic and anesthetic properties of ketamine, while its role in mediating the...